The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Dry Eye Syndrome Treatment-Global Market Insights and Sales Trends 2024

Dry Eye Syndrome Treatment-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1858464

No of Pages : 102

Ask Your Query

Synopsis
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
In this report, we mainly study the drugs and eye drops for dry eye.

The global Dry Eye Syndrome Treatment market size is expected to reach US$ 7375.6 million by 2029, growing at a CAGR of 4.5% from 2023 to 2029. The market is mainly driven by the significant applications of Dry Eye Syndrome Treatment in various end use industries. The expanding demands from the Hospital, Clinic and Home Care,, are propelling Dry Eye Syndrome Treatment market. Liquid Drops, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Gel segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Dry Eye Syndrome Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Dry Eye Syndrome Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Dry Eye Syndrome Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Dry Eye Syndrome Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Dry Eye Syndrome Treatment covered in this report include Novartis, Allergan, Otsuka, Santen Pharmaceutical, Nicox, Auven Therapeutics, Akorn, Bausch & Lomb and Alimera, etc.
The global Dry Eye Syndrome Treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation
Company Profiles:

  • Novartis
  • Allergan
  • Otsuka
  • Santen Pharmaceutical
  • Nicox
  • Auven Therapeutics
  • Akorn
  • Bausch & Lomb
  • Alimera
  • GlaxoSmithKline

Global Dry Eye Syndrome Treatment market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Dry Eye Syndrome Treatment market, Segment by Type:

  • Liquid Drops
  • Gel
  • Liquid Wipes
  • Eye Ointment
  • Other

Global Dry Eye Syndrome Treatment market, by Application

  • Hospital
  • Clinic
  • Home Care

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Dry Eye Syndrome Treatment manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Dry Eye Syndrome Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

Index

1 Dry Eye Syndrome Treatment Market Overview
1.1 Dry Eye Syndrome Treatment Product Overview
1.2 Dry Eye Syndrome Treatment Market Segment by Type
1.2.1 Liquid Drops
1.2.2 Gel
1.2.3 Liquid Wipes
1.2.4 Eye Ointment
1.2.5 Other
1.3 Global Dry Eye Syndrome Treatment Market Size by Type
1.3.1 Global Dry Eye Syndrome Treatment Market Size Overview by Type (2018-2029)
1.3.2 Global Dry Eye Syndrome Treatment Historic Market Size Review by Type (2018-2023)
1.3.3 Global Dry Eye Syndrome Treatment Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Dry Eye Syndrome Treatment Sales Breakdown by Type (2018-2023)
1.4.2 Europe Dry Eye Syndrome Treatment Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Dry Eye Syndrome Treatment Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Dry Eye Syndrome Treatment Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Dry Eye Syndrome Treatment Sales Breakdown by Type (2018-2023)
2 Global Dry Eye Syndrome Treatment Market Competition by Company
2.1 Global Top Players by Dry Eye Syndrome Treatment Sales (2018-2023)
2.2 Global Top Players by Dry Eye Syndrome Treatment Revenue (2018-2023)
2.3 Global Top Players by Dry Eye Syndrome Treatment Price (2018-2023)
2.4 Global Top Manufacturers Dry Eye Syndrome Treatment Manufacturing Base Distribution, Sales Area, Product Type
2.5 Dry Eye Syndrome Treatment Market Competitive Situation and Trends
2.5.1 Dry Eye Syndrome Treatment Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Dry Eye Syndrome Treatment Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dry Eye Syndrome Treatment as of 2022)
2.7 Date of Key Manufacturers Enter into Dry Eye Syndrome Treatment Market
2.8 Key Manufacturers Dry Eye Syndrome Treatment Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Dry Eye Syndrome Treatment Status and Outlook by Region
3.1 Global Dry Eye Syndrome Treatment Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Dry Eye Syndrome Treatment Historic Market Size by Region
3.2.1 Global Dry Eye Syndrome Treatment Sales in Volume by Region (2018-2023)
3.2.2 Global Dry Eye Syndrome Treatment Sales in Value by Region (2018-2023)
3.2.3 Global Dry Eye Syndrome Treatment Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Dry Eye Syndrome Treatment Forecasted Market Size by Region
3.3.1 Global Dry Eye Syndrome Treatment Sales in Volume by Region (2024-2029)
3.3.2 Global Dry Eye Syndrome Treatment Sales in Value by Region (2024-2029)
3.3.3 Global Dry Eye Syndrome Treatment Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Dry Eye Syndrome Treatment by Application
4.1 Dry Eye Syndrome Treatment Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Home Care
4.2 Global Dry Eye Syndrome Treatment Market Size by Application
4.2.1 Global Dry Eye Syndrome Treatment Market Size Overview by Application (2018-2029)
4.2.2 Global Dry Eye Syndrome Treatment Historic Market Size Review by Application (2018-2023)
4.2.3 Global Dry Eye Syndrome Treatment Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Dry Eye Syndrome Treatment Sales Breakdown by Application (2018-2023)
4.3.2 Europe Dry Eye Syndrome Treatment Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Dry Eye Syndrome Treatment Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Dry Eye Syndrome Treatment Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Dry Eye Syndrome Treatment Sales Breakdown by Application (2018-2023)
5 North America Dry Eye Syndrome Treatment by Country
5.1 North America Dry Eye Syndrome Treatment Historic Market Size by Country
5.1.1 North America Dry Eye Syndrome Treatment Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Dry Eye Syndrome Treatment Sales in Volume by Country (2018-2023)
5.1.3 North America Dry Eye Syndrome Treatment Sales in Value by Country (2018-2023)
5.2 North America Dry Eye Syndrome Treatment Forecasted Market Size by Country
5.2.1 North America Dry Eye Syndrome Treatment Sales in Volume by Country (2024-2029)
5.2.2 North America Dry Eye Syndrome Treatment Sales in Value by Country (2024-2029)
6 Europe Dry Eye Syndrome Treatment by Country
6.1 Europe Dry Eye Syndrome Treatment Historic Market Size by Country
6.1.1 Europe Dry Eye Syndrome Treatment Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Dry Eye Syndrome Treatment Sales in Volume by Country (2018-2023)
6.1.3 Europe Dry Eye Syndrome Treatment Sales in Value by Country (2018-2023)
6.2 Europe Dry Eye Syndrome Treatment Forecasted Market Size by Country
6.2.1 Europe Dry Eye Syndrome Treatment Sales in Volume by Country (2024-2029)
6.2.2 Europe Dry Eye Syndrome Treatment Sales in Value by Country (2024-2029)
7 Asia-Pacific Dry Eye Syndrome Treatment by Region
7.1 Asia-Pacific Dry Eye Syndrome Treatment Historic Market Size by Region
7.1.1 Asia-Pacific Dry Eye Syndrome Treatment Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Dry Eye Syndrome Treatment Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Dry Eye Syndrome Treatment Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Dry Eye Syndrome Treatment Forecasted Market Size by Region
7.2.1 Asia-Pacific Dry Eye Syndrome Treatment Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Dry Eye Syndrome Treatment Sales in Value by Region (2024-2029)
8 Latin America Dry Eye Syndrome Treatment by Country
8.1 Latin America Dry Eye Syndrome Treatment Historic Market Size by Country
8.1.1 Latin America Dry Eye Syndrome Treatment Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Dry Eye Syndrome Treatment Sales in Volume by Country (2018-2023)
8.1.3 Latin America Dry Eye Syndrome Treatment Sales in Value by Country (2018-2023)
8.2 Latin America Dry Eye Syndrome Treatment Forecasted Market Size by Country
8.2.1 Latin America Dry Eye Syndrome Treatment Sales in Volume by Country (2024-2029)
8.2.2 Latin America Dry Eye Syndrome Treatment Sales in Value by Country (2024-2029)
9 Middle East and Africa Dry Eye Syndrome Treatment by Country
9.1 Middle East and Africa Dry Eye Syndrome Treatment Historic Market Size by Country
9.1.1 Middle East and Africa Dry Eye Syndrome Treatment Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Dry Eye Syndrome Treatment Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Dry Eye Syndrome Treatment Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Dry Eye Syndrome Treatment Forecasted Market Size by Country
9.2.1 Middle East and Africa Dry Eye Syndrome Treatment Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Dry Eye Syndrome Treatment Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Information
10.1.2 Novartis Introduction and Business Overview
10.1.3 Novartis Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Novartis Dry Eye Syndrome Treatment Products Offered
10.1.5 Novartis Recent Development
10.2 Allergan
10.2.1 Allergan Company Information
10.2.2 Allergan Introduction and Business Overview
10.2.3 Allergan Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Allergan Dry Eye Syndrome Treatment Products Offered
10.2.5 Allergan Recent Development
10.3 Otsuka
10.3.1 Otsuka Company Information
10.3.2 Otsuka Introduction and Business Overview
10.3.3 Otsuka Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Otsuka Dry Eye Syndrome Treatment Products Offered
10.3.5 Otsuka Recent Development
10.4 Santen Pharmaceutical
10.4.1 Santen Pharmaceutical Company Information
10.4.2 Santen Pharmaceutical Introduction and Business Overview
10.4.3 Santen Pharmaceutical Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Santen Pharmaceutical Dry Eye Syndrome Treatment Products Offered
10.4.5 Santen Pharmaceutical Recent Development
10.5 Nicox
10.5.1 Nicox Company Information
10.5.2 Nicox Introduction and Business Overview
10.5.3 Nicox Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Nicox Dry Eye Syndrome Treatment Products Offered
10.5.5 Nicox Recent Development
10.6 Auven Therapeutics
10.6.1 Auven Therapeutics Company Information
10.6.2 Auven Therapeutics Introduction and Business Overview
10.6.3 Auven Therapeutics Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Auven Therapeutics Dry Eye Syndrome Treatment Products Offered
10.6.5 Auven Therapeutics Recent Development
10.7 Akorn
10.7.1 Akorn Company Information
10.7.2 Akorn Introduction and Business Overview
10.7.3 Akorn Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Akorn Dry Eye Syndrome Treatment Products Offered
10.7.5 Akorn Recent Development
10.8 Bausch & Lomb
10.8.1 Bausch & Lomb Company Information
10.8.2 Bausch & Lomb Introduction and Business Overview
10.8.3 Bausch & Lomb Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Bausch & Lomb Dry Eye Syndrome Treatment Products Offered
10.8.5 Bausch & Lomb Recent Development
10.9 Alimera
10.9.1 Alimera Company Information
10.9.2 Alimera Introduction and Business Overview
10.9.3 Alimera Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Alimera Dry Eye Syndrome Treatment Products Offered
10.9.5 Alimera Recent Development
10.10 GlaxoSmithKline
10.10.1 GlaxoSmithKline Company Information
10.10.2 GlaxoSmithKline Introduction and Business Overview
10.10.3 GlaxoSmithKline Dry Eye Syndrome Treatment Sales, Revenue and Gross Margin (2018-2023)
10.10.4 GlaxoSmithKline Dry Eye Syndrome Treatment Products Offered
10.10.5 GlaxoSmithKline Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Dry Eye Syndrome Treatment Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Dry Eye Syndrome Treatment Industrial Chain Analysis
11.4 Dry Eye Syndrome Treatment Market Dynamics
11.4.1 Dry Eye Syndrome Treatment Industry Trends
11.4.2 Dry Eye Syndrome Treatment Market Drivers
11.4.3 Dry Eye Syndrome Treatment Market Challenges
11.4.4 Dry Eye Syndrome Treatment Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Dry Eye Syndrome Treatment Distributors
12.3 Dry Eye Syndrome Treatment Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock